KARIS LEE: Open Payments
NPI 1568004612 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 9 payments from 7 companies in 2025. Trend: 2023 $800 · 2024 $940 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $259 |
| ABIOMED | 2 | $229 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| GENZYME CORPORATION | 1 | $68 |
Products named: Livdelzi, Epclusa, INGREZZA, Auvelity, AIRSUPRA, FABRAZYME.
Industry payments across FL — which companies pay providers there.
